MedPath

Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans

Terminated
Conditions
Smoking
Inflammation
Thrombosis
Registration Number
NCT02198937
Lead Sponsor
University of Zurich
Brief Summary

Investigation on the effect of smoking on thrombus formation in humans. The expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers will be assessed in 25-50 year old healthy smokers and non-smokers. The investigators are interested in possible differences between the two groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Smoker
  • Non-smokers
Exclusion Criteria
  • Disease
  • Pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers in bloodSingle time point, no follow-up (cross sectional)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital

🇨🇭

Zurich, Switzerland

University Hospital
🇨🇭Zurich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.